Fig. 2From: The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approachBURAN study design. ACQ-6, Asthma Control Questionnaire-6; AIRQ™-3 m, Asthma Impairment and Risk Questionnaire (3-month intervals); AIRQ™-12 m, Asthma Impairment and Risk Questionnaire (12-month intervals); BEC, blood eosinophil count; FRI, functional respiratory imaging; HRCT, high-resolution computed tomography; PFT, pulmonary function test; SGRQ, St George’s Respiratory QuestionnaireBack to article page